James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 29,400 shares at $43.70 ($1.3M) on 2021-04-12, disclosed to the SEC on 2021-04-14.
Open-market sale of $1.3M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.70 | 9,483 | $414K | 32.2% |
| 2 | $43.70 | 9,483 | $414K | 32.2% |
| 3 | $44.09 | 5,217 | $230K | 17.8% |
| 4 | $44.09 | 5,217 | $230K | 17.8% |
| Total | $43.84 avg | 29,400 | $1.3M | 100% |
| Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |
| DCPH | SELL | 2020-07-13 | $2.6M | — | Filing → |